Study Overview: This study is testing a drug called Rina-S for people with certain types of advanced cancer that have either spread in the body or can’t be removed by surgery. Rina-S is a special kind of medicine that targets cancer cells. The study aims to see if it's safe and how well it works.
Key Points:
- **Participation Length:** Treatment continues until the cancer worsens, side effects are too severe, or other specific reasons occur.
- **Eligibility:** Includes people with specific types of ovarian, endometrial, breast, lung, or other cancers that are hard to treat.
- **Study Parts:** Involves different groups focusing on specific cancer types and treatment responses.
Details: Participants will receive Rina-S until the cancer progresses, side effects become unacceptable, or they choose to stop. The study will examine how well the drug works against different cancer stages and what side effects might occur. Participants must have tried other treatments and have measurable cancer. Some people with lung disease or who’ve used similar drugs before may not be eligible.
Note: Always discuss with your doctor to understand the risks and benefits before joining.
How understandable was the trial content above?
Hard to understand
Easy to understand